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immunobiotics in Granulopoiesis
of immunocompromised Hosts
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The number of granulocytes is maintained by a regulated balance between granulopoiesis 
in the bone marrow and clearance and destruction in peripheral tissues. Granulopoiesis 
plays a fundamental role in the innate immune response. Therefore, factors affecting the 
normal granulopoiesis lead to alterations in innate defenses and reduce the resistance 
against infections. In this study, we give a description on recent advances regarding the 
molecular and cellular events that regulate steady-state and emergency granulopoiesis, 
which are crucial processes for the generation of protective innate immune responses. 
Particular attention will be given to emergency granulopoiesis alterations in immunosup-
pression states caused by malnutrition and chemotherapy. The role of microbiota in main-
taining a steady-state granulopoiesis and the immunological mechanisms involved are 
also discussed. Moreover, we describe the findings of our laboratory demonstrating that 
the dietary supplementation with immunobiotics is an interesting alternative to improve 
steady-state and emergency granulopoiesis, the respiratory innate immune response, 
and the resistance against respiratory pathogens in immunocompromised hosts.
Keywords: immunobiotics, granulopoiesis, immunocompromised hosts, respiratory infections, Lactobacillus 
rhamnosus CRL1505
inTRODUCTiOn
The microbiota is a complex community of bacteria, fungi, archaea, and viruses that colonize the 
mucosal surfaces and skin of the human body (1). The gut microbiota is typically integrated by 
bacteria and specifically by members of the divisions Bacteroidetes and Firmicutes (2). However, 
each individual’s microbiota is unique, and its composition depends on multiple factors, such as, 
diet, lifestyle, host genetic, use of antibiotics, and environment (3–5). The gut microbiota plays a 
fundamental role in the health maintenance of its host. In particular, we highlight that microbiota is 
able to control immunity in distant tissues through its capacity to regulate hematopoiesis at primary 
immune sites as the bone marrow (BM) (6). On the other hand, the immunomodulatory probiotic 
lactic acid bacteria (immunobiotics) are capable to improve the recovery of myeloid cells production 
affected by malnutrition or chemotherapy, and to increase the immune response against bacterial 
pathogens (7, 8). The mechanisms for systemic immunomodulation by the microbiota provide a 
probable mechanism for immunobiotics activity, demonstrating that translocated microbial prod-
ucts benefit the host by enhancing systemic innate immune function.
In this mini review, we examine the interaction between microbiota and immune system, and how 
this crosstalk affects the maintenance of a steady-state granulopoiesis that is crucial for the generation 
of protective innate immune responses. We also revise the alterations of emergency granulopoiesis 
in immunosuppression states caused by malnutrition and chemotherapy. In addition, we discuss 
TabLe 1 | Regulation of granulopoiesis by microbiota and 
immunobiotics.
experiemental models Outcome
Microbiota-granulopoiesis crosstalk
Polymyxin treated and 
germ-free (GF) mice (18)
Decreased levels of splenic and bone marrow (BM) 
progenitor cells forming GM-CFU colonies
Kanamycin-treated 
mice (17)
Decreased numbers of granulocytes in the BM and 
blood
GF mice
Antibiotic-treated mice
Nod1-deficient mice (23)
Translocation of peptidoglycan from the gut to 
neutrophils in the BM
Peptidoglycan concentrations in sera correlate with 
neutrophil function
Antimicrobial capacity of neutrophils depends on 
recognition of microbiota-derived peptidoglycan from 
Gram-negative bacteria via the pattern-recognition 
receptor Nod1 but not Nod2 orTLR4
Consistent with impaired innate priming Nod1-
deficient mice were unable to control Streptococcus 
pneumoniae early sepsis
GF mice
TLR4−/− mice
TRIF−/− mice
MyD88−/− mice (14)
Total lack of microbial colonization is associated with 
decreased neutrophil numbers and decreased G-CSF 
levels in the steady state
In vivo feedback is impaired in TLR4−/− and TRIF−/−, 
but not MyD88−/− animals
Steady-state neutrophil homeostasis is G-CSF-
dependent and regulated through pattern-recognition 
receptors, thereby directly linking toll-like receptor 
(TLR)-triggering to granulopoiesis
MyD88-deficient  
mice (20)
Loss of MyD88 reduce numbers and proliferation rate 
of hematopoietic stem cells in the BM
GF mice (27) Reduction of neutrophil recruitment to the peritoneal 
cavity in response to diverse stimuli including 
microbial components and sterile ligands
Microbiota-derived signals via a MyD88-dependent 
pathway are required to precondition the neutrophil 
inflammatory response
Antibiotic-treated 
neonatal mice
GF neonatal mice (16)
Decreased numbers of circulating and BM neutrophils 
and lower granulocyte-macrophages in the BM
Decreased number of interleukin (IL)-17-producing 
cells in the intestine and production of G-CSF
Increased susceptibility to Escherichia coli K1 and 
Klebsiella pneumoniae sepsis, which could be partially 
reversed by administration of G-CSF.
Microbiota-derived components, such as LPS via 
TLR4/MyD88 signaling, induced IL-17 production 
mainly by group 3 innate lymphoid cells in the 
intestine and increased plasma levels of G-CSF 
leading to granulocytosis
GF mice (19) Damage of differentiation of specific myeloid cell 
progenitors of both yolk sac and BM origin
Innate immune defects lead to impaired early 
responses to pathogens
GF mice (21) Complexity of the intestinal microbiota correlates 
with the number of BM myeloid cells
Transfer of sterile filtered, boiled serum from 
colonized mice was sufficient to expand the BM 
myeloid cell pool of GF mice in a MyD88/Toll-IL-1 
receptor-containing adaptor molecule-dependent 
manner, indicating that heat-stable, circulating, 
commensal-derived products may be responsible 
for maintaining steady-state myelopoiesis levels
experiemental models Outcome
Antibiotic-treated  
mice (28)
Impairment of resistance to lung infection with  
K. pneumoniae and reduction of ROS-mediated 
bacterial killing by alveolar macrophages and required 
Nod1- and Nod2- but not TLR-dependent signaling
GF mice
Antibiotic-treated  
mice (29)
Reduction steady-state numbers of tissue-resident 
and BM-derived phagocytes rendered GF and 
antibiotic-treated mice susceptible to acute systemic 
Lysteria monocytogenes infection
Neonatal non-obese 
diabetic mice (22)
The gut microbiota enriched in Staphylococcus in 
neonatal non-obese diabetic mice, correlated with 
increased immature granulocytes in the liver and 
spleen
immunobiotics-granulopoiesis crosstalk
Protein-malnourished 
mice (33)
Protein malnutrition altered B cell development 
in BM. The treatment of malnourished mice with 
Lactobacillus rhamnosus CRL1505 was able to 
induce a recovery of B cells that would explain its 
ability to increase immunity against infections
Protein-malnourished 
mice (35)
Repletion of malnourished mice with supplemental 
Lactobacillus rhamnosus improved neutrophils 
recruitment, phagocytic activity, and resistance 
against pneumococcal infection
Protein-malnourished 
mice (7)
Protein-malnutrition impaired the emergency 
myelopoiesis induced by the generation of the innate 
immune response against pneumococcal infection
Repletion of malnourished mice with Lactobacillus 
rhamnosus CRL1505 was able to accelerate the 
recovery of granulopoiesis and improve innate 
immunity
Chemotherapy-treated 
mice (8)
Lactobacillus casei CRL431 and Lactobacillus 
rhamnosus CRL1506 accelerated the recovery of 
Cy-caused myelosuppression and the recovery of the 
immune response against the opportunistic pathogen 
Candida albicans
Chemotherapy-treated 
mice (53)
Bifidobacterium longum BB536 increased resistance 
to sepsis caused by an intestinal infection of 
Pseudomonas aeruginosa in mice treated with Cy
Chemotherapy-treated 
mice (42, 54)
Lactobacillus plantarum HY7712 as Lactobacillus 
casei HY7213 accelerated the recovery of Cy-induced 
immunosuppression by immunopotentiating NK cells 
and cytotoxic T lymphocytes derived from BM 
and spleen, in addition to restoring the phagocytic 
capacity of peritoneal macrophages
Chemotherapy-treated 
mice (55)
Lactobacillus plantarum stimulated the proliferation of 
splenocytes from mice immunocompromised by Cy 
treatment in response to LPS
(Continued )
TabLe 1 | Continued
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the research of our laboratory demonstrating that dietary sup-
plementation with immunobiotics is an interesting alternative to 
improve steady-state and emergency granulopoiesis, respiratory 
innate immune response, and resistance against respiratory 
pathogens in immunocompromised hosts.
GRanULOPOieSiS anD iTS ReGULaTiOn 
bY THe GUT MiCRObiOTa
Granulocytes are key players of the innate immune response. 
They are short-lived cells, and their number is kept by a balance 
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between BM granulopoiesis and peripheral tissues’ clearance and 
destruction (9). These cells are continuously generated in steady-
state conditions from long-lived self-renewing hematopoietic 
stem cells (HSCs) that give rise to short-lived HSCs and multipo-
tent progenitors (MPPs) in BM. MPPs differentiate into common 
lymphoid and myeloid progenitors (CMP). CMPs give rise to 
granulocyte-macrophage (GMP), megakaryocyte-erythrocytes, 
and dendritic cell progenitors. Neutrophils, monocytes, as well 
as other granulocyte populations derive from GMPs (10). In 
front of an infectious challenge, neutrophils are recruited in large 
numbers to the infected tissues, the hematopoietic system must 
rapidly respond to the demand of these cells by turning from the 
steady-state to an emergency granulopoiesis (11).
The tissue macrophages activate the LRX family transcrip-
tion factors during the ingestion of apoptotic neutrophils in 
steady-state granulopoiesis. This, in turn, suppresses the pro- 
inflammatory cytokines’ production (12). Those macrophages 
decrease their production of interleukin (IL)-23 and thereby 
reduce the stimulus for IL-17 production by innate lymphoid 
cells, natural killer T cells, γδ-T cells, or Th17 cells. The reduced 
IL-17 levels account for low G-CSF expression (13). Involvement 
of IL-23/IL-17/G-CSF axis in regulation of granulopoiesis was 
confirmed in several independent murine models (14) and human 
studies (15). Moreover, steady-state neutrophil homeostasis is 
G-CSF-dependent and regulated through pattern-recognition 
receptors (PRRs), thereby directly linking Toll-like receptor 
(TLR)-triggering to granulopoiesis (14). Microbiota-derived 
components, such as LPS via TLR4/MyD88 signaling, induced 
intestinal IL-17 production and increased plasma levels of G-CSF 
leading to granulocytosis (16). Studies using antibiotics-treated 
and germ-free (GF) mice showed a decrease in GMPs in BM, and 
a lower number of neutrophils in the periphery (16–20). Further-
more, it was reported that a live complex flora is needed to restore 
granulopoiesis completely (21, 22). By using MyD88-deficient 
mice, it was shown that MyD88-dependent TLR signaling induced 
by microbiota can impact on the early hematopoietic develop-
ment and terminal myeloid differentiation (20, 21) (Table 1).
During emergency granulopoiesis, pathogen-associated mol-
ecule patterns (PAMPs) are detected by PRRs of innate immune 
system. In addition, bacteria and bacteria-derived products 
(e.g., LPS) are sensed by TLR-expressing endothelial cells. 
Consequently, the granulopoiesis and the neutrophils’ release 
into the circulation are produced by the increased amounts of 
G-CSF and GM-CSF (11). A large body of evidence suggests 
that circulating microbiota-derived products or pathogens may 
reach the BM or extramedullar sites, where they can be directly 
sensed by HSPCs and committed myeloid progenitors (23, 24). 
On the other hand, circulating HSCs can encounter bacteria 
or their products in the periphery before re-entering the BM 
(10). LPS-sensing by hematopoietic cells is dispensable for the 
induction of emergency granulopoiesis. TLR4 and MyD88 
expression of non-hematopoietic cell type is absolutely required 
for this process (25, 26). Thus, levels of growth factors determine 
the rate at which neutrophils are induced the proliferation and 
differentiation of neutrophil precursors by JAK–STAT pathways. 
In this context, transcription factor C/EBP-α regulates steady-
state granulopoiesis, whereas C/EBP-β is critical for triggering 
emergency granulopoiesis in response to GM-CSF (11). On the 
other hand, recent studies demonstrate that microbiota priming 
is required for neutrophil extravasation to injured tissues after 
inflammatory stimuli (27). In addition, antimicrobial capacity of 
neutrophils was shown to be dependent on the recognition of 
microbiota-derived peptidoglycan from Gram-negative bacteria 
via Nod1 but not Nod2 or TLR4 (23). An example of the systemic 
effect of gut microbiota on granulopoiesis during infection has 
been provided by a research work demonstrating that early 
innate resistance to Klebsiella pneumoniae lung infection was 
impaired in microbiota-depleted mice, and that the peptidogly-
can translocated from the gut was able to modulate the systemic 
innate immunity (28). Therefore, factors affecting the normal 
granulopoiesis lead to alterations in innate defenses and reduce 
the resistance against pathogens (23, 28, 29) (Table 1).
GRanULOPOieSiS anD MaLnOURiSHeD 
HOSTS
Granulopoietic homeostasis requires an important cellular 
renewal, because of the cells’ generation and death. Approximately 
0.5–1.0 × 1011 granulocytes are generated each day during steady-
state conditions in adults (11). In contrast to local infection that 
can be contained by the innate immune response, in severe infec-
tions, the emergency granulopoiesis is triggered and neutrophilia 
occurs. Therefore, the hematopoietic system is capable of rapid 
adaptation when augmenting cellular output several-fold levels 
to respond to the higher demand for neutrophils (10). Steady-
state growth and development, physical activity, and response to 
serious illness are affected by nutritional status (30). In agreement 
to several research works, we have established that malnutrition 
affects the hematopoietic tissue that has a high turnover rate 
and cell proliferation, inducing a damage of blood cells produc-
tion and causing hypoplasia and histological alterations of BM 
(31–33). This is characterized by a reduction of hematopoietic 
space, which is occupied by components of extracellular matrix 
(31, 33). These histological alterations may be responsible for the 
damage of the hematopoietic niches, which may influence the 
crosstalk between hematopoietic cells and the growth factors 
that regulate the granulopoiesis. In line with Borelli et al. (34), 
a reduction of GMPs was observed in BM of malnourished mice 
that could explain the reduction of myeloid cells of BM and blood 
(7, 35). Thus, nutritional deficiencies affect hematopoiesis, lead-
ing to an immunocompromised condition (35).
The relationship between malnutrition and infection can be 
viewed under two aspects: malnutrition compromising host 
defense, or infections either aggravating a previously existing 
deficient nutritional status or triggering malnutrition through 
disease pathogenesis. It was described that malnutrition alters 
both innate and adaptive immune responses as consequence 
of multiple abnormalities induced in the immune system (36). 
Herrera et  al. (7) demonstrated that protein-malnutrition sig-
nificantly reduces the capacity to recruit neutrophils into infected 
lungs and that this effect could be related to impairment in granu-
lopoiesis. Several factors could be involved in the impairment of 
emergency granulopoiesis in malnourished mice, in addition 
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to those mentioned above. CXCL12 expression in response to 
pneumococcal infection in BM requires special attention. The 
HSCs homing into BM is regulated by CXCL12 and their recep-
tor CXCR4 (9). There is no change in the expression of CXCL12 
during an infection in malnourished mice, which could be a 
mechanism for the preservation of HSCs in the BM. Malnutrition 
also impairs the expression of both GM-CSF and IL-1 in BM and 
contributes to the altered emergency granulopoietic response (7). 
It is known that the steady-state and emergency granulopoiesis 
are directed by GM-CSF while the BM stromal cells function is to 
support hematopoiesis mainly regulated by IL-1 (37). Hence, the 
neutrophilia induced by infection or inflammation is assisted by 
both GM-CSF and IL-1, which in turn accelerates granulopoiesis 
by expanding MPP and CMP compartments (38). Thus, the 
reduced capacity of malnourished hosts to develop adequate 
levels of GM-CSF may explain BM’s defective response against 
an infectious challenge.
On the other hand, there is a great increase in the number of 
patients with secondary immunodeficiencies related to chemo-
therapeutic treatments. Cyclophosphamide (Cy) is a drug widely 
used as an antineoplastic alkylating agent because of its significant 
therapeutic range and broad spectrum of activity to treat different 
types of cancer (39). For the World Health Organization, Cy is 
one of the essential medicines needed in a health system (40). 
However, this drug induces serious side effects, such as apoptosis 
and necrosis in BM cells (41), alterations of basal and emergency 
hematopoiesis, immunosuppression (8, 42), increased suscepti-
bility to infections (8, 43), and even change of intestinal micro-
biota composition (44). Because of the increased susceptibility to 
infections, chemotherapy is commonly used in combination with 
antibiotics in cancer therapy (45). Paradoxically, the consequent 
propagation of antibiotic resistance among pathogens and deple-
tion of intestinal microbiota lead to increased vulnerability of 
these patients. For these reasons, it is vital to support treatments 
aimed at recovering the hematopoietic capacity to increase the 
efficiency of the immune response triggered in infectious hemat-
opoietic alternative resources processes.
Can ORaL aDMiniSTRaTiOn  
OF iMMUnObiOTiCS ReGULaTe 
GRanULOPOieSiS?
In the last years, a number of research project were meant to find 
alternative treatments to favor hematopoiesis, improve immunity, 
booster anticancer effects, and clear anticancer drugs (46). A long 
list of health benefits has been described for immunobiotics, are 
likely to modulate and enhance immunity functions in malnour-
ished mice (8, 47–49) (Table 1).
Therefore, when the diet induced Lactobacillus casei CRL431 
or Lactobacillus rhamnosus CRL1505, the recovery of the res-
piratory immunity in immunocompromised hosts was reduced 
from 21 to 7 days (32, 50, 51). Furthermore, the supplementa-
tion of repletion diet with immunobiotics induced recovery of 
mielopoyesis and normalization of emergency granulopoiesis in 
response to pneumococcal infection (7, 32). We demonstrated 
that the treatments with immunobiotics were efficient to recover 
the architecture of BM tissue, subendosteal epithelium, and BM 
cellularity altered by malnutrition (7). Moreover, the administra-
tion of L. rhamnosus CRL1505 induced the growth of mitotic pool 
cells, mature myeloid cells, and neutrophils in BM. Although the 
mechanisms involved are not completely elucidated, it is known 
that cell wall components reach the gut mucosa and from there 
to circulation during colonization of gut mucosa by commensal 
bacteria or probiotics. Indeed, the detection of peptidoglycan 
in the neutrophil fraction shows that it can accumulate in the 
BM (23). Considering these findings, a probable mechanism 
for the immunobiotic activity of the microbiota was observed, 
demonstrating that microbial products favor the systemic innate 
immune function of the host.
On the other hand, it was described that some immunobiotics 
can influence ILs levels in blood, which agree with our findings 
demonstrating the capacity of immunobiotics to normalize the 
levels of TNF-α, IL-1β, IL-4, IL-6, and IL-10 in malnourished 
mice (52). It is probably that the changes in ILs levels induced 
by immunobiotics could influence on the normalization of 
granulopoiesis. Moreover, we demonstrated for the first time 
that dietary supplementation with immunobiotics can modulate 
the production of GM-CSF in infected lungs and its expression 
in the BM. Moreover, immunobiotics modulate the CXCR4/
CXCL12 signaling axis, which is associated with the recovery 
of hematopoiesis induced by L. rhamnosus CRL1505 (7). The 
detailed study of the mechanisms that explain the influence of 
immunobiotics on the regulation of granulopoiesis in BM is an 
interesting topic for future investigations.
Some works have described beneficial effects of immunobiot-
ics on myelosuppression and immunosuppression in Cy-treated 
mice, although no deep mechanistic studies were performed (8, 
42, 53–55) (Table 1). Taking into consideration the  capacity of 
L. casei CRL431 and L. rhamnosus CRL1506 to modulate hemat-
opoiesis in malnourished mice, we also aimed to evaluate  the 
ability of these immunobiotic strains in Cy-treated mice. We 
showed that preventive treatment with immunobiotics is capable 
to increase GMPs in BM (CD34+ and CD34+Gr-1+ cells), which 
enables a prompt recovery of peripheral blood neutrophils after 
Cy-administration (8). These immunobiotic treatments were 
also able to improve recruitment of phagocytic cells to the site 
of infection and increase resistance against Candida albicans 
(8). Further studies to evaluate the mechanisms involved in 
these activities are needed. However, these results support the 
idea that immunobiotic strains can improve the recovery from 
Cy-immunosuppression, enhancing myeloid population in BM. 
Therefore, immunobiotics can serve as alternatives to reduce 
the immunosuppression in patients treated with chemotherapy 
drugs.
COnCLUDinG ReMaRKS
This review exposes wide evidence that the gut microbiota 
regulates granulocyte homeostasis, and therefore influences 
the host’s innate immune response. Additionally, research 
from the last years demonstrated that the oral administra-
tion of immunobiotics improves the recovery of steady-state 
granulopoiesis and stimulate the emergency granulopoiesis 
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in malnourished and Cy-immunocompromised host. Future 
research is needed in order to elucidate the mechanisms by 
which specific immunobiotic strains enhance the recovery of 
granulopoiesis in immunocompromised hosts. Although the 
use of colony-stimulating factors can reduce the increased risk 
of infections induced by chemotherapy treatments, they are also 
the cause of several important side effects including bone pain, 
low-grade fever, and fatigue. Interestingly, the results expressed 
provide the basis for new applications of immunobiotics in 
order to stimulate the production of neutrophils and other 
types of leukocytes in the BM which would strength the ability 
of the host to fight against infections, without the side effects 
observed for stimulating factors. Certainly, this immunobiotic 
effect would improve the quality of life of patients receiving 
chemotherapy.
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